omics

NantHealth, a subsidiary of NantWorks, LLC, today announced it has completed the acquisition of Harris Corporation’s (NYSE:HRS) commercial Healthcare Solutions business, a clinical systems integration innovator. Harris retained its government healthcare services business. NantHealth’s existing cOS, eviti and omics platforms, combined with Harris’ FusionFX® suite of products, delivers on the promise of whole health systems integration and revolutionizes the patient-clinician experience by bringing molecular medicine insights directly to the point-of-care.

Read More »